MedPath

Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Not Applicable
Completed
Conditions
Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
Interventions
Other: Baduanjin exercise
Registration Number
NCT03162133
Lead Sponsor
Guangdong Provincial People's Hospital
Brief Summary

A 12-week randomized controlled trail was conducted in 72 Chinese breast cancer survivors who had received aromatase inhibitors treatment for more than 6 months. All participants were assigned to either 12 weeks of Baduanjin classes which involved to two 90-minute sessions per week or a wait-list control. Participants completed fitness assessments, measurements of lipopolysaccharide-stimulated production of proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), interleukin-1β(IL-1β) ,C-reactive protein (CRP) ,BMI,BMD and questionnaires to measure QoL, fatigue, sleep quality, Aromatase Inhibitor-Induced Arthralgia, symptoms of climacteric syndrome were completed at baseline and 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
86
Inclusion Criteria
  • Have been diagnosed as stage I to III breast cancer 0.5 to 4.0 years before enrollment
  • Taking an AI (aromatase inhibitors ),and had been receiving an AI for at least 6 months
Exclusion Criteria
  • A prior history of breast or any other cancer except basal or squamous cell skin cancer Inflammatory breast cancer
  • With exercise contraindications:chronic obstructive pulmonary disease, uncontrolled hypertension, evidence of liver or kidney failure, symptomatic ischemic heart disease ,conditions involving the immune system such as autoimmune and/or inflammatory diseases, cognitive impairment, alcohol/drug abuse
  • Current Baduanjin practice (within the last 6 months), and/or previous Baduanjin practice for more than 3 months
  • Women reporting 5 hours or more of vigorous physical activity per week

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Exercise groupBaduanjin exerciseAfter completing the baseline tests, participants in exercise group were instructed to attend 90-minute, supervised Baduanjin exercise 2 times per week. The Baduanjin intervention used the standardized Baduanjin training program, designed by the General Administration of Sports of China. Two senior Baduanjin teachers from Guangzhou Sports University conducted the training.
Waiting list Control groupBaduanjin exerciseParticipants assigned to the wait-list control were told to continue performing their usual care and daily activities, and to refrain from doing any Baduanjin exercise. After their post-assessment they were able to attend the Baduanjin classes.
Primary Outcome Measures
NameTimeMethod
Change from Baseline Quality of Life (QoL) at 3 monthsat baseline and 3 months

European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30 version 3 (EORTC QLQ-C30)

Secondary Outcome Measures
NameTimeMethod
Change from Baseline Flexibility test at 3 monthsat baseline and 3 months

Test of scratching his back and Sit in the chair and reach

Change from Baseline BMI at 3 monthsat baseline and 3 months

Body Mass Index

Change from Baseline Aromatase Inhibitor-Induced Arthralgia at 3 monthsat baseline and 3 months

Brief Pain Inventory-Short Form

Change from Baseline BMD at 3 monthsat baseline and 3 months

Bone mineral density

Change from Baseline IL-1β at 3 monthsat baseline and 3 months

interleukin-1β

Change from Baseline CRP at 3 monthsat baseline and 3 months

C-reactive protein

Change from Baseline IL-6 at 3 monthsat baseline and 3 months

proinflammatory cytokines interleukin-6

Change from Baseline Fatigue at 3 monthsat baseline and 3 months

Piper fatigue questionnaire

Change from Baseline sleep quality at 3 monthsat baseline and 3 months

Pittsburgh sleep quality index, PSQI

Change from Baseline Symptoms of climacteric syndrome at 3 monthsat baseline and 3 months

Kupperman Index

Change from Baseline Aerobic Fitness Assessment at 3 monthsat baseline and 3 months

Six-min walk test (6MWT)

Change from Baseline Muscle strength test at 3 monthsat baseline and 3 months

Upper strength: hand grip (measured by a dynamometer; the average of 3 readings) lower limb strength:sit-to-stand (measured as number of reps in a 30-s period)

Change from Baseline Balance test at 3 monthsat baseline and 3 months

stand on one foot

Change from Baseline TNF-α at 3 monthsat baseline and 3 months

tumor necrosis factor alpha

Trial Locations

Locations (1)

Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath